CN104352524A - Cod Liver Oil Ointment for Hemorrhoids and Anal Fissures - Google Patents
Cod Liver Oil Ointment for Hemorrhoids and Anal Fissures Download PDFInfo
- Publication number
- CN104352524A CN104352524A CN201410554116.XA CN201410554116A CN104352524A CN 104352524 A CN104352524 A CN 104352524A CN 201410554116 A CN201410554116 A CN 201410554116A CN 104352524 A CN104352524 A CN 104352524A
- Authority
- CN
- China
- Prior art keywords
- parts
- liver oil
- hemorrhoids
- seal
- cod
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003026 cod liver oil Substances 0.000 title claims abstract description 27
- 235000012716 cod liver oil Nutrition 0.000 title claims abstract description 27
- 208000014617 hemorrhoid Diseases 0.000 title claims abstract description 25
- 206010002153 Anal fissure Diseases 0.000 title claims abstract description 21
- 208000016583 Anus disease Diseases 0.000 title claims abstract description 21
- 208000009531 Fissure in Ano Diseases 0.000 title claims abstract description 21
- 239000002674 ointment Substances 0.000 title claims abstract description 21
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000011787 zinc oxide Substances 0.000 claims abstract description 19
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 18
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229940116229 borneol Drugs 0.000 claims abstract description 18
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 18
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 18
- 210000004185 liver Anatomy 0.000 claims abstract description 18
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims abstract description 17
- 241000402754 Erythranthe moschata Species 0.000 claims abstract description 17
- 229940037003 alum Drugs 0.000 claims abstract description 17
- 239000003921 oil Substances 0.000 claims abstract description 17
- 235000019198 oils Nutrition 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 229940099259 vaseline Drugs 0.000 claims abstract description 13
- 238000003756 stirring Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 6
- 239000004264 Petrolatum Substances 0.000 claims description 4
- 229940066842 petrolatum Drugs 0.000 claims description 4
- 235000019271 petrolatum Nutrition 0.000 claims description 4
- HGOMLSWXJIICBL-UHFFFAOYSA-F dialuminum;zinc;tetrasulfate;tetracosahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al+3].[Al+3].[Zn+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O HGOMLSWXJIICBL-UHFFFAOYSA-F 0.000 claims description 2
- -1 30 parts of alum Chemical compound 0.000 claims 1
- 238000002844 melting Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 208000003251 Pruritus Diseases 0.000 abstract description 5
- 230000007803 itching Effects 0.000 abstract description 5
- 230000029663 wound healing Effects 0.000 abstract description 5
- 206010015150 Erythema Diseases 0.000 abstract description 4
- 206010036772 Proctalgia Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 208000025865 Ulcer Diseases 0.000 abstract description 3
- 231100000397 ulcer Toxicity 0.000 abstract description 3
- 206010042674 Swelling Diseases 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 abstract description 2
- 208000027418 Wounds and injury Diseases 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 210000000436 anus Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 210000002255 anal canal Anatomy 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 235000019166 vitamin D Nutrition 0.000 description 3
- 239000011710 vitamin D Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 206010002180 Anal ulcer Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 206010065360 Anal prolapse Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010042343 Subcutaneous abscess Diseases 0.000 description 1
- 208000026062 Tissue disease Diseases 0.000 description 1
- 208000010011 Vitamin A Deficiency Diseases 0.000 description 1
- 206010047626 Vitamin D Deficiency Diseases 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 230000009786 epithelial differentiation Effects 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
- A61K35/06—Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Endocrinology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及药物技术领域,具体来说是一种用于治疗痔疮、肛裂的鱼肝油软膏;由下列重量份数的原料制成:海豹肝油85~110份、麝香20~40份、氧化锌40~60份、白矾15~37份、冰片1~2份、氮酮0.5~1.5份、凡士林2~3份;本发明所提供软膏,易于涂抹于患处,保护伤口,促进伤口愈合,消炎、止痒。具有消腐生肌收敛、消炎、止痒、清热止痛、促进伤口愈合的功效。对于治疗皮肤黏膜溃疡、肛周痛痒红肿有显著的疗效,有效率能达到100%,副作用小。具有疗效确切、使用方便、起效迅速、安全无痛、质量好等优点,优于现有技术。The present invention relates to the field of pharmaceutical technology, specifically a cod liver oil ointment for treating hemorrhoids and anal fissures; it is made of the following raw materials in parts by weight: 85-110 parts of seal liver oil, 20-40 parts of musk, 40-60 parts of zinc oxide, 15-37 parts of alum, 1-2 parts of borneol, 0.5-1.5 parts of azone, and 2-3 parts of vaseline; the ointment provided by the present invention is easy to apply to the affected area, protect the wound, promote wound healing, and relieve inflammation and itching. It has the effects of eliminating rot, promoting tissue regeneration, astringing, relieving inflammation, relieving itching, clearing away heat and relieving pain, and promoting wound healing. It has a significant therapeutic effect for treating skin and mucosal ulcers, perianal pain, itching, redness and swelling, and the effective rate can reach 100%, with little side effects. It has the advantages of definite efficacy, convenient use, rapid onset, safety and painlessness, good quality, etc., and is superior to the prior art.
Description
技术领域 technical field
本发明涉及药物技术领域,具体来说是一种用于治疗痔疮、肛裂的鱼肝油软膏。 The invention relates to the technical field of medicines, in particular to cod liver oil ointment for treating hemorrhoids and anal fissures.
背景技术 Background technique
肛裂是齿状线以下肛管皮肤破裂形成棱形裂口或溃疡,是一种常见的肛管疾病,好发于青壮年,儿童也可发生,老年人较少。多是大便秘结,排便过于用力,使肛门皮肤破裂造成的。从感染学角度来说,主要是肛门后部的肛隐窝感染,炎症向肛管皮下部蔓延,致使皮下脓肿破溃而成肛裂。肛裂后可引起肛周红肿,肛周溃疡,肛周疼痛等肛周疾病。 Anal fissure is a prismatic fissure or ulcer formed by the rupture of the anal canal skin below the dentate line. It is mostly caused by constipation, excessive defecation, and rupture of the anal skin. From the perspective of infection, it is mainly the anal crypt infection at the back of the anus, and the inflammation spreads to the subcutaneous part of the anal canal, resulting in the rupture of subcutaneous abscess and anal fissure. Anal fissure can cause perianal redness, perianal ulcer, perianal pain and other perianal diseases.
痔(haemorrhoids)是直肠末端黏膜、肛管皮肤下痔静脉丛屈曲和扩张而形成的柔软静脉团。是发生在肛门内外的常见病、多发病。任何年龄均可发病,以20~40岁多见,大多数病人随年龄增长而加重。有关痔的发病机制目前尚无定论,多数学者认为是“血管性肛管垫”,是正常解剖的一部分,只有合并出血、肛脱垂、疼痛等症状时,才能称为病。 Hemorrhoids (haemorrhoids) are soft veins formed by the flexion and expansion of the hemorrhoidal venous plexus under the mucosa of the end of the rectum and the skin of the anal canal. It is a common disease and frequently-occurring disease that occurs inside and outside the anus. It can occur at any age, and it is more common in the age of 20 to 40. Most patients get worse with age. The pathogenesis of hemorrhoids is still inconclusive. Most scholars believe that it is a "vascular anal canal cushion", which is a part of normal anatomy. Only when symptoms such as bleeding, anal prolapse, and pain are combined, can it be called a disease.
鱼肝油中主要是维生素A和D。维生素A的主要功能是维持机体正常生长、生殖、视觉、上皮组织健全及抗感染免疫功能。维生素A缺乏时可引起:小儿骨骼发育迟缓;影响牙齿牙釉质细胞发育,牙齿不健全;上皮组dcxc.xyygf.com冬虫夏草胶囊织结构受损;免疫功能低下容易引起呼吸道、消化道和泌尿道的各种感染。维生素D的主要功能是促进小肠黏膜对钙、磷的吸收;促进肾小管对钙磷的重吸收。维生素D缺乏时可引起:钙磷经肠道吸收减少,骨样组织钙化障碍;佝偻病,表现为易惊、多汗、烦躁和骨骼改变。 Cod liver oil is mainly vitamin A and D. The main function of vitamin A is to maintain the normal growth, reproduction, vision, epithelial tissue integrity and anti-infection immune function of the body. Vitamin A deficiency can cause: children's bone development retardation; affect the development of tooth enamel cells, and the teeth are not perfect; the structure of the epithelial tissue is damaged; Various infections. The main function of vitamin D is to promote the absorption of calcium and phosphorus by the small intestinal mucosa; to promote the reabsorption of calcium and phosphorus by the renal tubules. Vitamin D deficiency can cause: reduced intestinal absorption of calcium and phosphorus, calcification of bone-like tissue disorders; rickets, manifested as easy to startle, sweating, irritability and bone changes.
目前治疗痔疮、肛裂的药物比较多,但是存在见效慢、不彻底、易复发组方复杂,对身体有副作用的缺点。 At present, there are many medicines for treating hemorrhoids and anal fissure, but they have the disadvantages of slow effect, incompleteness, easy recurrence and complex prescriptions, and side effects on the body.
发明内容 Contents of the invention
本发明的目的是针对上述存在的问题,提供一种利用海豹鱼肝油为主要原料,对痔疮、肛裂有显著疗效的软膏。 The object of the present invention is to address the above-mentioned problems and provide an ointment that uses seal cod liver oil as the main raw material and has significant curative effects on hemorrhoids and anal fissures.
为实现上述目的,本发明采用的技术方案是:一种治疗痔疮、肛裂的鱼肝油软膏,由下列重量份数的原料制成:海豹肝油85~110份、麝香20~40份、氧化锌40~60份、白矾15~37份、冰片1~2份、氮酮0.5~1.5份、凡士林2~3份。 In order to achieve the above object, the technical solution adopted in the present invention is: a cod liver oil ointment for treating hemorrhoids and anal fissure, made of the following raw materials in parts by weight: 85-110 parts of seal liver oil, 20-40 parts of musk, 40 parts of zinc oxide ~60 parts, 15~37 parts of alum, 1~2 parts of borneol, 0.5~1.5 parts of azone, 2~3 parts of petrolatum.
进一步的,由下列重量份数的原料制成:海豹肝油90~100份、麝香25~35份、氧化锌45~55份、白矾17~34份、冰片1~2份、氮酮0.5~1.3份、凡士林2~3份。 Further, it is made from the following raw materials in parts by weight: 90-100 parts of seal liver oil, 25-35 parts of musk, 45-55 parts of zinc oxide, 17-34 parts of alum, 1-2 parts of borneol, 0.5-1.3 parts of azone 2 to 3 parts of Vaseline.
进一步的,由下列重量份数的原料制成:海豹肝油95份、麝香25份、氧化锌50份、白矾30份、冰片1.5份、氮酮1.5份、凡士林2.5份。 Further, it is prepared from the following raw materials in parts by weight: 95 parts of seal liver oil, 25 parts of musk, 50 parts of zinc oxide, 30 parts of alum, 1.5 parts of borneol, 1.5 parts of azone, and 2.5 parts of petrolatum.
一种疗痔疮、肛裂的鱼肝油软膏的制备方法,将麝香、氧化锌和白矾原料粉碎后过筛备用;将冰片、氮酮和熔化后凡士林加入至上述粉碎后的细粉中,进行搅拌,在搅拌过程中加入海豹鱼肝油,混匀至半凝固即得。 A preparation method of cod-liver oil ointment for treating hemorrhoids and anal fissures. The raw materials of musk, zinc oxide and alum are pulverized and sieved for later use; borneol, azone and melted vaseline are added to the pulverized fine powder and stirred. Add seal cod liver oil in the stirring process, and mix until semi-solidified.
进一步的,将麝香20~40份、氧化锌40~60份和白矾15~37份原料粉碎后过筛备用;将冰片1~2份、氮酮0.5~1.5份和熔化后凡士林2~3份加入至上述粉碎后的细粉中,进行搅拌,在搅拌过程中加入海豹鱼肝油85~110份,混匀至半凝固即得。 Further, 20-40 parts of musk, 40-60 parts of zinc oxide and 15-37 parts of alum are crushed and sieved for later use; 1-2 parts of borneol, 0.5-1.5 parts of azone and 2-3 parts of melted vaseline Add to the crushed fine powder, stir, add 85 to 110 parts of seal cod liver oil during the stirring, and mix until semi-solidified.
本发明的有益技术效果是: The beneficial technical effect of the present invention is:
本发明中,鱼肝油中主要是维生素A 和D,维生素A 的主要功能是维持机体正常生长、生殖、上皮组织健全及抗感染免疫功能,能促进上皮分化,帮助维护皮肤和粘膜的健康;氧化锌可以促使皮损部位组织细胞间隙缩小,水肿消退,渗出减少,达到干燥,抗炎,促进皮损恢复等作用;冰片有止痛防腐的作用,可用于神经痛及消炎,粘膜、皮下组织均易吸收。 In the present invention, cod liver oil mainly contains vitamins A and D, and the main function of vitamin A is to maintain normal growth, reproduction, epithelial tissue integrity and anti-infection immune function of the body, can promote epithelial differentiation, and help maintain the health of skin and mucous membranes; zinc oxide It can promote the narrowing of tissue cell gaps in skin lesions, subside edema, reduce exudation, achieve dryness, anti-inflammation, and promote the recovery of skin lesions; absorb.
本发明将鱼肝油,氧化锌按适宜比例组成混合,发挥了协同效应,各自组分的作用都彼此增强,可以有针对性地治疗肛周疾病,尤其对肛周红肿、肛周溃疡、肛周疼痛或肛周伤口愈合有显著效果。加入冰片,可进一步地增强止痛防腐的作用。 In the present invention, cod liver oil and zinc oxide are mixed according to appropriate proportions, and a synergistic effect is exerted, the effects of the respective components are mutually enhanced, and perianal diseases can be treated in a targeted manner, especially for perianal redness, perianal ulcer, and perianal pain Or perianal wound healing has a significant effect. Adding borneol can further enhance the analgesic and antiseptic effect.
总之,本发明所提供软膏,易于涂抹于患处,保护伤口,促进伤口愈合,消炎、止痒。具有消腐生肌收敛、消炎、止痒、清热止痛、促进伤口愈合的功效。对于治疗皮肤黏膜溃疡、肛周痛痒红肿有显著的疗效,有效率能达到100%,副作用小。具有疗效确切、使用方便、起效迅速、安全无痛、质量好等优点,优于现有技术。 In a word, the ointment provided by the present invention is easy to apply on the affected part, protects the wound, promotes wound healing, reduces inflammation and relieves itching. It has the effects of eliminating putrefaction and promoting muscle convergence, anti-inflammatory, antipruritic, heat-clearing and pain-relieving, and promoting wound healing. It has a remarkable curative effect on the treatment of skin and mucous membrane ulcers, itching, redness and swelling around the anus, the effective rate can reach 100%, and the side effects are small. The invention has the advantages of definite curative effect, convenient use, rapid onset of effect, safety and painlessness, good quality, etc., and is superior to the prior art.
具体实施方式 Detailed ways
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。 The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Apparently, the described embodiments are only some of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.
实施例1 Example 1
海豹肝油的制备方法 Preparation method of seal liver oil
1)海豹肝的贮藏:将海豹加工副产物海豹肝,清洗后,-18~-22℃以下冷冻贮藏; 1) Storage of seal liver: the seal liver, a by-product of seal processing, is cleaned and stored in a freezer below -18~-22°C;
2)预处理:将海豹肝解冻,切碎; 2) Pretreatment: Thaw the seal liver and chop it;
3)酶解:向水解锅中加入水,使液固比(mL/g)为1:1~2:1,加盐酸调节pH 为5.5~6.5,加入海豹肝1.5~2.5%(质量)的木瓜蛋白酶,密封,置于恒温振荡器中,在转速为100~150r/min,温度40~50℃下酶解3~4h ; 3) Enzymolysis: Add water to the hydrolysis pot to make the liquid-solid ratio (mL/g) 1:1-2:1, add hydrochloric acid to adjust the pH to 5.5-6.5, add 1.5-2.5% (mass) of seal liver Papain, sealed, placed in a constant temperature oscillator, enzymatically hydrolyzed at a speed of 100-150r/min and a temperature of 40-50°C for 3-4 hours;
4)灭酶处理后离心分离:酶解结束,加盐酸调节pH 至3~3.5,使复合蛋白酶变性失活,将其置于低速大容量离心机中,在转速4000~5000r/min 趁热离心5~15min,分离得上层粗海豹肝油;第一次离心产生的中层脂蛋白乳状液采用冻结解冻破乳方法,即酶解液在-18~-22℃冻结10~14h,38~42℃解冻1~2h 进行破乳,然后再次离心分离; 4) Centrifugal separation after enzymatic treatment: after enzymatic hydrolysis, add hydrochloric acid to adjust the pH to 3-3.5 to denature and inactivate the complex protease, put it in a low-speed large-capacity centrifuge, and centrifuge while it is hot at a speed of 4000-5000r/min After 5-15 minutes, the upper layer of crude seal liver oil was separated; the middle lipoprotein emulsion produced by the first centrifugation was demulsified by freezing and thawing, that is, the enzymatic solution was frozen at -18-22°C for 10-14 hours, and then thawed at 38-42°C 1 to 2 hours for demulsification, and then centrifuged again;
5)精炼:用700~900g/L的柠檬酸脱胶,添加量为油量的0.5~1.5%(体积);用250~350g/L的烧碱—纯碱混合物(质量比1.8~2.2:1)脱酸,添加量为油量1.5~2.5%(体积);用活性白土脱色,添加量为油量的8~11%(质量);在80~90℃下减压蒸馏5~15min 进行脱臭; 5) Refining: Use 700-900g/L citric acid for degumming, the amount added is 0.5-1.5% (volume) of the oil; use 250-350g/L caustic soda-soda ash mixture (mass ratio 1.8-2.2:1) for degumming Acid, the amount added is 1.5-2.5% (volume) of the oil; decolorized with activated clay, the amount added is 8-11% (mass) of the oil; deodorized by vacuum distillation at 80-90°C for 5-15 minutes;
6)低温处理:将精制海豹肝油在3~5d 的时间内缓慢降到3~8℃,然后降到-2℃~-3℃,需10~20h,滤去固脂得海豹肝清油,然后采用抽真空冲氮包装。 6) Low-temperature treatment: Slowly lower the refined seal liver oil to 3-8°C within 3-5 days, and then drop to -2°C--3°C for 10-20 hours, filter out the solid fat to obtain seal liver oil, and then Packed with vacuum pumped nitrogen.
实施例2 Example 2
一种治疗痔疮、肛裂的鱼肝油软膏,由下列重量份数的原料制成:海豹肝油85份、麝香40份、氧化锌40份、白矾37份、冰片1份、氮酮1.5份、凡士林2份。 A cod liver oil ointment for treating hemorrhoids and anal fissure, which is made of the following raw materials in parts by weight: 85 parts of seal liver oil, 40 parts of musk, 40 parts of zinc oxide, 37 parts of alum, 1 part of borneol, 1.5 parts of azone, and 2 parts of vaseline share.
一种治疗痔疮、肛裂的鱼肝油软膏的制备方法,将麝香40份、氧化锌40份和白矾37份原料粉碎后过筛备用;将冰片1份、氮酮1.5份和熔化后凡士林2份加入至上述粉碎后的细粉中,进行搅拌,在搅拌过程中加入海豹鱼肝油85份,混匀至半凝固即得。 A preparation method of cod-liver oil ointment for treating hemorrhoids and anal fissures. The raw materials of 40 parts of musk, 40 parts of zinc oxide and 37 parts of alum are crushed and sieved for later use; 1 part of borneol, 1.5 parts of azone and 2 parts of melted vaseline are added Into the fine powder after the above pulverization, stir, add 85 parts of seal cod liver oil in the stirring process, mix until semi-solidified.
实施例3 Example 3
一种治疗痔疮、肛裂的鱼肝油软膏,由下列重量份数的原料制成:海豹肝油110份、麝香20份、氧化锌60份、白矾15份、冰片2份、氮酮0.5份、凡士林3份。 A cod liver oil ointment for treating hemorrhoids and anal fissure, which is made of the following raw materials in parts by weight: 110 parts of seal liver oil, 20 parts of musk, 60 parts of zinc oxide, 15 parts of alum, 2 parts of borneol, 0.5 part of azone, and 3 parts of vaseline share.
一种治疗痔疮、肛裂的鱼肝油软膏的制备方法,将麝香20份、氧化锌60份和白矾15份原料粉碎后过筛备用;将冰片2份、氮酮0.5份和熔化后凡士林3份加入至上述粉碎后的细粉中,进行搅拌,在搅拌过程中加入海豹鱼肝油110份,混匀至半凝固即得。 A preparation method of cod-liver oil ointment for treating hemorrhoids and anal fissures. The raw materials of 20 parts of musk, 60 parts of zinc oxide and 15 parts of alum are pulverized and sieved for later use; 2 parts of borneol, 0.5 parts of azone and 3 parts of melted vaseline are added Add to the fine powder after pulverization, stir, add 110 parts of seal cod liver oil in the stirring process, and mix until semi-solidified.
实施例4 Example 4
一种治疗痔疮、肛裂的鱼肝油软膏,由下列重量份数的原料制成:海豹肝油95份、麝香25份、氧化锌50份、白矾30份、冰片1.5份、氮酮1.5份、凡士林2.5份。 A cod liver oil ointment for treating hemorrhoids and anal fissures, which is made of the following raw materials in parts by weight: 95 parts of seal liver oil, 25 parts of musk, 50 parts of zinc oxide, 30 parts of alum, 1.5 parts of borneol, 1.5 parts of azone, and 2.5 parts of vaseline share.
一种治疗痔疮、肛裂的鱼肝油软膏的制备方法,将麝香25份、氧化锌50份和白矾30份原料粉碎后过筛备用;将冰片1.5份、氮酮1.5份和熔化后凡士林2.5份加入至上述粉碎后的细粉中,进行搅拌,在搅拌过程中加入海豹鱼肝油95份,混匀至半凝固即得。 A preparation method of cod-liver oil ointment for treating hemorrhoids and anal fissures. The raw materials of 25 parts of musk, 50 parts of zinc oxide and 30 parts of alum are pulverized and sieved for later use; 1.5 parts of borneol, 1.5 parts of azone and 2.5 parts of melted vaseline are added Into the above-mentioned pulverized fine powder, stir, add 95 parts of seal cod liver oil in the stirring process, and mix until semi-solidified.
实施例5 Example 5
将上述实施例2、3、4中的产品进行临床验证。 The products in the above-mentioned Examples 2, 3, and 4 are clinically verified.
150例痔疮患者,男74例,女76例,1-2期内痔45例,3期混合痔71例,单纯性外痔54例;病程20年以上的13例,10年以上患者44例,5年以上患者46例; 150 patients with hemorrhoids, 74 males and 76 females, 45 cases of 1-2 internal hemorrhoids, 71 cases of 3rd stage mixed hemorrhoids, 54 cases of simple external hemorrhoids; 46 patients over 10 years old;
用药方法:本发明软膏涂抹于肛门周围,或用棉条涂抹软膏寿缓慢插如肛门内,6-8小时用药一次,一周一个疗程。 Medication method: the ointment of the present invention is applied around the anus, or the ointment is smeared with a cotton sliver and slowly inserted into the anus, once every 6-8 hours, one course of treatment a week.
除5例好转外,其余均治愈,治愈率100%。 Except 5 cases improved, the rest were cured, the cure rate was 100%.
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。 The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention shall be included in the scope of the present invention. within the scope of protection.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410554116.XA CN104352524A (en) | 2014-10-20 | 2014-10-20 | Cod Liver Oil Ointment for Hemorrhoids and Anal Fissures |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410554116.XA CN104352524A (en) | 2014-10-20 | 2014-10-20 | Cod Liver Oil Ointment for Hemorrhoids and Anal Fissures |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104352524A true CN104352524A (en) | 2015-02-18 |
Family
ID=52519897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410554116.XA Pending CN104352524A (en) | 2014-10-20 | 2014-10-20 | Cod Liver Oil Ointment for Hemorrhoids and Anal Fissures |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104352524A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101181551A (en) * | 2007-12-05 | 2008-05-21 | 陶登保 | Externally used unction for curing hemorrhoid |
CN102579500A (en) * | 2012-02-24 | 2012-07-18 | 北京市肛肠医院 | Compound cod-liver oil ointment as well as preparation method and application thereof |
-
2014
- 2014-10-20 CN CN201410554116.XA patent/CN104352524A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101181551A (en) * | 2007-12-05 | 2008-05-21 | 陶登保 | Externally used unction for curing hemorrhoid |
CN102579500A (en) * | 2012-02-24 | 2012-07-18 | 北京市肛肠医院 | Compound cod-liver oil ointment as well as preparation method and application thereof |
Non-Patent Citations (2)
Title |
---|
吴杲等主编: "《科学合理用药》", 31 January 2013 * |
宋修俭等: "鲨鱼油口服乳的制备", 《沈阳药学院学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kara | Burn etiology and pathogenesis | |
CN103948807A (en) | Formula and preparation method of paste capable of removing slough and promoting tissue regeneration | |
Randall | Idiopathic gangrene of the scrotum | |
CN104352524A (en) | Cod Liver Oil Ointment for Hemorrhoids and Anal Fissures | |
KR101067443B1 (en) | Topical injectable compositions for the treatment of hemorrhoids containing hydroxychloroquine | |
CN104398868B (en) | A kind of herbal mixture for treating hemorrhoid | |
CN101849982B (en) | Ointment for treating frostbite rhagadia | |
CN101513478B (en) | External application ointment for treating III stage angiitis | |
CN103040900A (en) | Medicine for treating bedsores | |
CN103028044B (en) | Paste for treating burns and scalds | |
CN108403721B (en) | Water stone haemorrhoids ointment and preparation method thereof | |
CN101264133A (en) | Externally-applied medicine for treating hemorrhoid | |
CN118286149B (en) | Composition for treating rheumatic bone pain, preparation method and application thereof | |
US20170143768A1 (en) | Ointment for the treatment of hemorrhoidal disease | |
CN116036225B (en) | A naturally derived external pharmaceutical composition for treating arthritis | |
CN114470067B (en) | Traditional Chinese medicine compound for treating phlebitis and preparation method and application thereof | |
CN110403983B (en) | Natural product composition for treating hemorrhoids and preparation method thereof | |
CN108553532A (en) | A kind of antibacterial ointment and preparation method thereof for treating hemorrhoid | |
CN105943655A (en) | Compound ointment for treating hemorrhoids and preparation method of compound ointment | |
CN101837007A (en) | Medicinal composition for curing hemorrhoids and preparation method thereof | |
CN101647938B (en) | Medicament for treating burn and scald and preparation method thereof | |
CN110403995B (en) | Traditional Chinese medicine composition for treating superficial phlebitis and preparation, use methods and application thereof | |
CN118001344A (en) | Medicine for preventing and treating hemorrhoids and preparation method thereof | |
CN101417121A (en) | Medicine capable of curing skin burning and freezing injury | |
CN106983799A (en) | A kind of pharmaceutical composition of granulation tissue hyperplasia around therapeutic community's veins indwelling catheter mouth of pipe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150218 |
|
WD01 | Invention patent application deemed withdrawn after publication |